National Comprehensive Cancer Network



About NCCN

Soft Tissue Sarcoma Panel - Disclosures as of 4/28/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Robert S. Benjamin, MD

Johnson & Johnson;
Immune Design

None

None

None

Johnson & Johnson;
Merck & Co., Inc.;
Pfizer Inc.

9/5/2014

Mary Anne Bergman

None

None

None

None

None

4/9/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

Sarah Boles, MD

None

None

None

None

None

8/25/2014

Marilyn M. Bui, MD, PhD

None

None

None

None

None

9/5/2014

Ernest U. Conrad III, MD

None

None

None

None

None

3/21/2012

Jose Costa, MD, FACP

         

Pending

Fayna Ferkle, PharmD

None

None

None

None

None

4/9/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Kristen N. Ganjoo, MD

None

None

EMD Serono/Advisory Board

None

None

8/15/2014

Suzanne George, MD

ARIAD Pharmaceuticals, Inc.;
Bayer HealthCare;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Blueprint

None

None

Abbott Laboratories;
AbbVie

8/30/2014

Ricardo J. Gonzalez, MD

None

None

Novartis Pharmaceuticals Corporation

None

None

1/27/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

Martin J. Heslin, MD

None

None

None

None

None

5/9/2014

John M. Kane III, MD

None

None

None

None

None

7/16/2014

Joel Mayerson, MD

Millennium Pharmaceuticals, Inc.

None

None

None

None

4/21/2015

Martin McCarter, MD

None

None

None

None

None

5/2/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Sean V. McGarry, MD

None

DePuy/Synthes;
Musculoskeletal Transplant Foundation

None

None

None

2/11/2015

Christian Meyer, MD, PhD

None

None

None

None

None

9/3/2014

Richard J. O'Donnell, MD

None

None

None

None

None

9/3/2014

Alberto S. Pappo, MD

None

None

;
Ziopharm

None

None

1/12/2015

I. Benjamin Paz, MD

None

None

Genomic Health, Inc.

None

None

9/23/2014

Ivy A. Petersen, MD

None

None

None

None

None

11/20/2014

John D. Pfeifer, MD, PhD

None

Novartis Pharmaceuticals Corporation;
Agilent;
Strand Analytical Labs

None

PierianDX, an NGS software vendor that currently has no cash value

None

9/8/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

4/6/2015

R. Lor Randall, MD, FACS

Children`s Oncology Group;
Connective tissue Oncology Society;
Musculoskeletal Tumor Society

Alan B. Slifka Foundation;
Biomet;
International Society of Paediatric Oncology;
Musculoskeletal Transplant Foundation;
Sarcoma Foundation of America

Biomet;
Musculoskeletal Transplant Foundation

Association of Bone and Joint Surgeons

None

2/19/2015

Richard F. Riedel, MD

Eisai Inc.;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Morphotek Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
ASTEX;
CytRx Corporation;
Infinity Pharmaceuticals;
Threshold;
Threshold;
Tracon;
Ziopharm

Morphotek Inc.;
Novartis Pharmaceuticals Corporation;
CytRx;
EMD Serono

None

None

None

3/21/2014

Jillian L. Scavone, PhD

None

None

None

None

None

11/7/2014

Scott Schuetze, MD, PhD

Amgen Inc.;
Johnson & Johnson;
AB Sciences;
CytRx;
SARC;
Threshold

None

None

None

None

9/16/2014

Karen D. Schupak, MD

None

None

None

None

None

9/5/2014

Herbert S. Schwartz, MD

None

None

Musculoskeletal Transplant Foundation

Musculoskeletal Transplant Foundation

None

1/25/2014

William D. Tap, MD

ImClone Systems Incorporated;
Morphotek Inc.;
Threshold Pharmaceuticals

Novartis Pharmaceuticals Corporation;
Plexxikon Pharmaceuticals

None

None

None

12/5/2013

Margaret von Mehren, MD

Eisai Inc.;
Johnson & Johnson;
Merck & Co., Inc.;
Morphotek Inc.;
Novartis Pharmaceuticals Corporation;
OSI Pharmaceuticals, Inc.;
Arog Pharmaceuticals;
Astex;
Sarcoma Alliance for Research through Collaboration;
Pfizer Inc.;
Synta Pharmaceuticals Corp.

Eisai Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

4/9/2015

Jeffrey D. Wayne, MD

None

Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

None

None

5/2/2014